Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Articles published by Centogene NV

CENTOGENE Data on Novel Genetic Risk Factor for Parkinson’s Disease in The Lancet Neurology
From Centogene NV
Via GlobeNewswire
Tickers CNTG CNTGF
CENTOGENE Receives Delisting Notice From Nasdaq
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Publication in Brain Journal Reveals 15% of Parkinson’s Disease Cases Are Linked to Genetic Factors
From Centogene NV
Via GlobeNewswire
Tickers CNTG
C-Path and CENTOGENE MOU to Enhance Collaboration in Lysosomal Disease Research and Drug Development
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Announces Adoption of All Resolutions Tabled at 2024 Annual General Meeting
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Reports Full Year 2023 Financial Results and Recent Business Highlights
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Secures Approx. $20 Million to Strengthen Cash Position
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE and Evotec Discover Promising New Molecule to Treat Gaucher Disease
From Centogene NV
Via GlobeNewswire
Tickers CNTG EVO
CENTOGENE Biodatabank Grows to Incorporate Disease Insights From Over 850,000 Diverse Patients
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Receives Nasdaq Non-Compliance Notice
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Extends Strategic Partnership With Takeda to Continue Providing Access to Genetic Testing for Patients With Lysosomal Storage Disorders
From Centogene NV
Via GlobeNewswire
Tickers CNTG TAK
CENTOGENE Collaborates on Research Published in Science Showing Immunopathological Landscape of Human Pre-TCRα Deficiency
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Announces Receipt of Nasdaq Notice of Delisting and Intention to Request a Hearing
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Explores Strategic Alternatives
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE and the Laboratory of Human Genetics of Infectious Diseases at Institut Imagine Announce Rare Disease Research Collaboration
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Receives French Research Tax Credit Accreditation
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE and The Michael J. Fox Foundation Announce Research Project to Validate Genetic Risk Factors of Parkinson’s Disease Using Multiomics
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Announces Preliminary Full Year 2023 Revenue
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Announces Voting Results of Extraordinary General Meeting
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE’s Frontotemporal Dementia (FTD) Genetic Study, EFRONT, Reaches Initial Patient Enrollment Milestone
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE and Lifera, a Public Investment Fund (PIF) Company, Complete Strategic Joint Venture Transaction
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE, University College London, and Global Team of Researchers Discover Gene Associated With New Neurodevelopmental Disease Linked to Early-Onset Dystonia and Parkinsonism
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Expands Multiomic Diagnostic Portfolio With Newly-Launched Transcriptomic Offering
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE to Present at H.C. Wainwright 25th Annual Global Investment Conference
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Reports First Half 2023 Financial Results
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Announces Publication Establishing Lyso-Gb1 as a Predictive Biomarker for Gaucher Disease Patients
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Receives Nasdaq Non-Compliance Notification Regarding Minimum Market Value of Publicly Held Shares Deficiency
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE to Participate in Upcoming Conferences in August
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Regains Compliance With Nasdaq Listing Requirements
From Centogene NV
Via GlobeNewswire
Tickers CNTG
CENTOGENE Biodatabank Reveals Unique Genetic Variants in World's Largest Niemann-Pick Type C1 Disease Cohort
From Centogene NV
Via GlobeNewswire
Tickers CNTG
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.